“…Positron emission tomography (PET) and magnetic resonance imaging (MRI) are often used to diagnose AD and detect neurotransmitter activity disorders, amyloid beta plaque deposition, and brain atrophy (Ewers et al, 2011;McKhann et al, 2011;Sperling et al, 2011). As methods focused on functional neural activity, studies based on the temporal behavior of neural activity were conducted using electroencephalography (EEG), magnetoencephalography (MEG), and functional magnetic resonance imaging (fMRI) (Greicius et al, 2004;Jeong, 2004;Stam, 2005;Dickerson and Sperling, 2008;Takahashi, 2013;Yang and Tsai, 2013;Wang et al, 2017;Nobukawa et al, 2020). Among all these evaluations, EEG is cost-effective, widely available, and non-invasive, making it ideal for clinical applications (Vecchio et al, 2013;Kulkarni and Bairagi, 2018).…”